Adapting epicutaneous patch testing protocols to assess immediate‐type skin reactions

International Journal of Cosmetic Science, vol. 42, pp. 328–335

Abstract

OBJECTIVE: During the development of cosmetic formulations, in vitro and in vivo methods are essential tools used to reliably assess the skin irritation potential of a product or ingredient. Epicutaneous patch testing (single and/or multiple application protocols) has long been used as an initial in vivo method to screen for possible skin irritation properties of a substance or formulation. To confirm the mildness and dermatological and/or consumer acceptance of a product, use tests are often subsequently conducted. A study was therefore initiated to see how well patch test results correlate with use tests with respect to irritation elicited by skincare (leave-on) products. METHODS/RESULTS: A number of different cosmetic formulations were assessed in both tests. Although the patch test results did not indicate substantial irritation potentials, immediate-type reactions (stinging and redness) were observed in some volunteers which disappeared within approx. 1 h. Although transient, these reactions suggested that consumer acceptance would probably be low and the studies were discontinued. Immediate-type reactions are rare but have been described for some substances used in cosmetics. These unexpected results were nevertheless intriguing and prompted the start of a journey to see if patch test protocols could be modified to assess these reactions. An occlusive short-term patch test protocol with an application period of 20 min was developed. Successful identification of the spontaneous reactions became possible. Furthermore, there was a correlation between the intensity of reactions observed in the short-term patch test and those observed in the controlled in-use studies. Short-term patch testing using the developed protocol can therefore reliably be used as a screening method, for example in the development and optimization of cosmetic formulations containing ingredients that could cause spontaneous reactions, for instance of non-immunological contact urticaria type. CONCLUSION: The lessons learned from this studies indicate that simple modifications of existing test protocols can lead to important insights into skin reactions. These modifications can then be used to create further building blocks in the development and optimization of test strategies for cosmetic formulations which offer reliable study designs for possible reactions product developers may encounter.

Authors 10

1. Annette Mehling

   BASF (Germany)

   Affiliation as printed

   BASF Personal Care and Nutrition GmbH Duesseldorf Germany

   BASF Personal Care and Nutrition GmbH, Duesseldorf, Germany

2. Nicole Braun corresponding

   Witten/Herdecke University · DermaTronnier

   Affiliation as printed

   DermaTronnier GmbH & Co. KG, Institute for Experimental Dermatology at Witten/Herdecke University Witten Germany

3. Joachim Degwert

   SGS Germany GmbH (Germany)

   Affiliation as printed

   SGS SIT GmbH Skin Investigation and Technology Hamburg Germany

   SGS SIT GmbH, Skin Investigation and Technology, Hamburg, Germany

4. M. Duttine
   Affiliation as printed

   WIN COSMETIC GmbH & Co.KG Floersheim‐Dalsheim Germany

5. H.F. Merk Aachen

   RWTH Aachen University

   Affiliation as printed

   RWTH Aachen University Aachen Germany

   RWTH Aachen University, Aachen, Germany

6. Uwe Rossow
   Affiliation as printed

   CCR GmbH & Co. KG Eschweiler Germany

7. Julia Welzel

   University Hospital Augsburg

   Affiliation as printed

   Universitätsklinikum Augsburg Augsburg Germany

8. W. Wigger‐Alberti
   Affiliation as printed

   BioSkin GmbH Hamburg Germany

   BioSkin GmbH, Hamburg, Germany

9. Klaus‐Peter Wilhelm
   Affiliation as printed

   proDERM Institut für Angewandte Dermatologische Forschung GmbH Hamburg Germany

10. Joachim Ennen
    Affiliation as printed

    SkinNEXT Consulting Hamburg Germany

    SkinNEXT Consulting, Hamburg, Germany